Deal Capsule - April 2018 | KPMG | DE

Deal Capsule - April 2018

Deal Capsule - April 2018

M&A activity remains robust, despite a decline in chemicals deal value.

1000

Contact

Partner, Head of Chemicals & Pharmaceuticals

KPMG AG Wirtschaftsprüfungsgesellschaft

Contact

Related content

Reagenzgläser

Topic of this issue:

Transaction focus in life sciences heavily weighted towards hematology – four of top five deals in this area. Chemicals saw one of the largest financial investors deals. Digitalization, in particular, is driving transactions and cooperations with technology players. In Q1 2018, US and China were the most active countries in both sectors.

Online Version

Browse directly through the publication

KPMG Deal Capsule Newsletter

© 2018 KPMG AG Wirtschaftsprüfungsgesellschaft, ein Mitglied des KPMG-Netzwerks unabhängiger Mitgliedsfirmen, die KPMG International Cooperative (“KPMG International”), einer juristischen Person schweizerischen Rechts, angeschlossen sind. Alle Rechte vorbehalten.

Connect with us

 

Request for proposal

 

Submit